Filing Flows › DBV Technologies S.A. (DBVT) › Who owns the stock
Who owns DBV Technologies S.A. (DBVT) stock
69 funds reported DBV Technologies S.A. (DBVT) shares in their latest 13F filings, worth $341M in all. The largest holder is MPM BioImpact LLC ($60.1M). Last quarter 32 funds added to their stakes and 32 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| MPM BioImpact LLC | 3,666,284 | $60.1M | new | 2026-06-30 |
| Siren, L.L.C. | 1,857,362 | $30.5M | unchanged | 2026-06-30 |
| Vivo Capital, LLC | 1,844,758 | $30.3M | decrease | 2026-06-30 |
| Perceptive Advisors LLC | 1,653,350 | $27.1M | increase | 2026-06-30 |
| Baker Bros. Advisors LP | 1,461,425 | $24.0M | unchanged | 2026-06-30 |
| Artisan Partners Limited Partnership | 1,372,851 | $22.5M | decrease | 2026-06-30 |
| UBS Group AG | 1,313,439 | $21.5M | increase | 2026-06-30 |
| Morgan Stanley | 954,908 | $15.7M | increase | 2026-06-30 |
| Logos Global Management LP | 915,000 | $15.0M | new | 2026-06-30 |
| Patient Square Capital LP | 909,474 | $14.9M | increase | 2026-06-30 |
| Octagon Capital Advisors LP | 574,200 | $9.4M | unchanged | 2026-06-30 |
| ADAR1 Capital Management, LLC | 528,295 | $8.7M | decrease | 2026-06-30 |
| Redmile Group, LLC | 410,440 | $6.7M | decrease | 2026-06-30 |
| Duquesne Family Office LLC | 383,363 | $6.3M | unchanged | 2026-06-30 |
| Ameriprise Financial | 378,497 | $6.2M | increase | 2026-06-30 |
DBV Technologies S.A.'s latest quarter
DBV Technologies S.A., Q3 2026: revenue $1.6M (-43% year over year), net loss $64.5M, operating cash flow −$51.5M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most DBVT stock?
By the latest 13F filings: MPM BioImpact LLC ($60.1M); Siren, L.L.C. ($30.5M); Vivo Capital, LLC ($30.3M); Perceptive Advisors LLC ($27.1M); Baker Bros. Advisors LP ($24.0M).
What is the short interest in DBVT?
872,075 shares were sold short at the 2026-10-15 settlement, -22.43% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.